Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000323270 | SCV000332391 | likely benign | not specified | 2015-07-07 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000323270 | SCV000841538 | benign | not specified | 2019-12-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087588 | SCV001107252 | benign | Temtamy preaxial brachydactyly syndrome | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001564172 | SCV001787293 | likely benign | not provided | 2020-03-05 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV001087588 | SCV002800302 | likely benign | Temtamy preaxial brachydactyly syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001564172 | SCV005216299 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003939939 | SCV004751273 | likely benign | CHSY1-related disorder | 2019-07-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |